DIA465.06-0.42 -0.09%
SPY655.83+0.59 0.09%
QQQ584.98+0.67 0.11%

Earnings Scheduled For March 26, 2026

Benzinga·03/26/2026 11:11:17
Listen to the news

Companies Reporting Before The Bell

• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.

• MapLight Therapeutics (NASDAQ:MPLT) is estimated to report earnings for its fourth quarter.

• Whitefiber (NASDAQ:WYFI) is expected to report quarterly loss at $0.11 per share on revenue of $23.43 million.

• Buda Juice (AMEX:BUDA) is likely to report earnings for its Fiscal Year 2025.

• Lovesac (NASDAQ:LOVE) is projected to report quarterly earnings at $2.11 per share on revenue of $242.69 million.

• Designer Brands (NYSE:DBI) is estimated to report quarterly loss at $0.49 per share on revenue of $714.95 million.

• REX American Resources (NYSE:REX) is expected to report earnings for its fourth quarter.

• Cognition Therapeutics (NASDAQ:CGTX) is projected to report earnings for its fourth quarter.

• Commercial Metals (NYSE:CMC) is projected to report quarterly earnings at $1.30 per share on revenue of $2.04 billion.

• Lumexa Imaging Holdings (NASDAQ:LMRI) is estimated to report quarterly earnings at $0.05 per share on revenue of $263.24 million.

• Shoe Carnival (NASDAQ:SCVL) is estimated to report quarterly earnings at $0.33 per share on revenue of $253.74 million.

• BRP (NASDAQ:DOO) is estimated to report quarterly earnings at $1.49 per share on revenue of $1.69 billion.

• Rockwell Medical (NASDAQ:RMTI) is estimated to report quarterly earnings at $0.03 per share on revenue of $18.57 million.

• 22nd Century Group (NASDAQ:XXII) is expected to report quarterly loss at $2.10 per share on revenue of $4.05 million.

• Pony AI (NASDAQ:PONY) is likely to report quarterly earnings at $0.22 per share on revenue of $23.93 million.

• electroCore (NASDAQ:ECOR) is expected to report quarterly loss at $1.40 per share on revenue of $41.01 million.

• Innate Pharma (NASDAQ:IPHA) is likely to report quarterly loss at $0.65 per share on revenue of $7.23 million.

• CollPlant Biotechnologies (NASDAQ:CLGN) is expected to report quarterly loss at $0.19 per share on revenue of $6.77 million.

• Acumen Pharmaceuticals (NASDAQ:ABOS) is estimated to report earnings for its fourth quarter.

• Quoin Pharmaceuticals (NASDAQ:QNRX) is projected to report earnings for its fourth quarter.

• Hyperion DeFi (NASDAQ:HYPD) is estimated to report quarterly loss at $4.62 per share on revenue of $500 thousand.

• Lucid Diagnostics (NASDAQ:LUCD) is likely to report quarterly loss at $0.08 per share on revenue of $1.34 million.

Companies Reporting After The Bell

• Veritone (NASDAQ:VERI) is expected to report quarterly loss at $0.07 per share on revenue of $34.86 million.

• Wrap Technologies (NASDAQ:WRAP) is likely to report earnings for its fourth quarter.

• SKYX Platforms (NASDAQ:SKYX) is estimated to report quarterly loss at $0.06 per share on revenue of $25.19 million.

• Oxford Industries (NYSE:OXM) is projected to report quarterly earnings at $0.04 per share on revenue of $369.53 million.

• Blink Charging (NASDAQ:BLNK) is expected to report quarterly loss at $0.11 per share on revenue of $28.56 million.

• Dare Bioscience (NASDAQ:DARE) is projected to report quarterly loss at $0.35 per share on revenue of $1.03 million.

• Insight Molecular (NASDAQ:IMDX) is projected to report quarterly loss at $0.24 per share on revenue of $285 thousand.

• Argan (NYSE:AGX) is expected to report quarterly earnings at $1.98 per share on revenue of $255.17 million.

• Rani Therapeutics Hldgs (NASDAQ:RANI) is projected to report quarterly loss at $0.05 per share on revenue of $7.00 million.

• Spero Therapeutics (NASDAQ:SPRO) is estimated to report earnings for its fourth quarter.

• Southland Holdings (AMEX:SLND) is estimated to report quarterly loss at $0.19 per share on revenue of $211.63 million.

• Innovate (NYSE:VATE) is expected to report earnings for its fourth quarter.

• BitGo Holdings (NYSE:BTGO) is expected to report quarterly loss at $0.41 per share on revenue of $6.09 billion.

• Alpha Cognition (NASDAQ:ACOG) is likely to report quarterly loss at $0.32 per share on revenue of $3.92 million.

• P3 Health Partners (NASDAQ:PIII) is estimated to report quarterly loss at $8.16 per share on revenue of $357.65 million.

• Westport Fuel Systems (NASDAQ:WPRT) is projected to report quarterly loss at $0.49 per share on revenue of $1.16 million.

• Xos (NASDAQ:XOS) is projected to report quarterly loss at $0.60 per share on revenue of $11.50 million.

• VirTra (NASDAQ:VTSI) is likely to report quarterly loss at $0.03 per share on revenue of $5.40 million.

• CapsoVision (NASDAQ:CV) is estimated to report quarterly loss at $0.15 per share on revenue of $4.26 million.

• Iridex (NASDAQ:IRIX) is expected to report quarterly loss at $0.02 per share on revenue of $14.74 million.

• Worksport (NASDAQ:WKSP) is likely to report quarterly loss at $0.40 per share on revenue of $7.28 million.

• Braskem (NYSE:BAK) is estimated to report quarterly loss at $0.98 per share on revenue of $3.22 billion.

• Newsmax (NYSE:NMAX) is estimated to report quarterly loss at $0.08 per share on revenue of $44.39 million.

• Laird Superfood (AMEX:LSF) is estimated to report quarterly loss at $0.06 per share on revenue of $13.13 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.